相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mass spectrometry imaging identifies abnormally elevated brain L-DOPA levels and extrastriatal monoaminergic dysregulation in L-DOPA-induced dyskinesia
Elva Fridjonsdottir et al.
SCIENCE ADVANCES (2021)
Simultaneous mass spectrometry imaging of multiple neuropeptides in the brain and alterations induced by experimental parkinsonism and L-DOPA therapy
Heather Hulme et al.
NEUROBIOLOGY OF DISEASE (2020)
μ Opioid Receptor Agonism for L-DOPA-Induced Dyskinesia in Parkinson's Disease
Erwan Bezard et al.
JOURNAL OF NEUROSCIENCE (2020)
Five Decades of Research on Opioid Peptides: Current Knowledge and Unanswered Questions
Lloyd D. Fricker et al.
MOLECULAR PHARMACOLOGY (2020)
Substance P plays a critical role in synaptic transmission in striatal neurons
Zi-Xuan He et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Comprehensive mapping of neurotransmitter networks by MALDI-MS imaging
Mohammadreza Shariatgorji et al.
NATURE METHODS (2019)
DPI-289, a novel mixed delta opioid agonist/mu opioid antagonist (DAMA), has L-DOPA-sparing potential in Parkinson's disease.
Tom H. Johnston et al.
NEUROPHARMACOLOGY (2018)
Levodopa-induced dyskinesia in Parkinson disease: Current and evolving concepts
Alberto J. Espay et al.
ANNALS OF NEUROLOGY (2018)
Dual -agonist/-antagonist opioid receptor modulation reduces levodopa-induced dyskinesia and corrects dysregulated striatal changes in the nonhuman primate model of Parkinson disease
Lisa F. Potts et al.
ANNALS OF NEUROLOGY (2015)
Intranigral administration of substance P receptor antagonist attenuated levodopa-induced dyskinesia in a rat model of Parkinson's disease
Xinxin Yang et al.
EXPERIMENTAL NEUROLOGY (2015)
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
Matthieu F. Bastide et al.
PROGRESS IN NEUROBIOLOGY (2015)
Widespread Monoaminergic Dysregulation of Both Motor and Non-Motor Circuits in Parkinsonism and Dyskinesia
Michel Engeln et al.
CEREBRAL CORTEX (2015)
Neuropeptides: Metabolism to Bioactive Fragments and the Pharmacology of Their Receptors
Mathias Hallberg
MEDICINAL RESEARCH REVIEWS (2015)
Abnormal structure-specific peptide transmission and processing in a primate model of Parkinson's disease and L-DOPA-induced dyskinesia
Mathieu Bourdenx et al.
NEUROBIOLOGY OF DISEASE (2014)
The NK1 receptor antagonist N-acetyl-L-tryptophan reduces dyskinesia in a hemi-parkinsonian rodent model
Emma Thornton et al.
PARKINSONISM & RELATED DISORDERS (2014)
L-dopa-induced dyskinesia: beyond an excessive dopamine tone in the striatum
Gregory Porras et al.
SCIENTIFIC REPORTS (2014)
PSD-95 expression controls L-DOPA dyskinesia through dopamine D1 receptor trafficking
Gregory Porras et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
A critique of available scales and presentation of the non-human primate dyskinesia rating scale
Susan H. Fox et al.
MOVEMENT DISORDERS (2012)
Treatment with a Substance P Receptor Antagonist Is Neuroprotective in the Intrastriatal 6-Hydroxydopamine Model of Early Parkinson's Disease
Emma Thornton et al.
PLOS ONE (2012)
Purkinje Cell Protein 4 Positively Regulates Neurite Outgrowth and Neurotransmitter Release
Shin-ichi Harashima et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2011)
L-DOPA-induced Dyskinesia is Associated with Regional Increase of Striatal Dynorphin Peptides as Elucidated by Imaging Mass Spectrometry
Jorg Hanrieder et al.
MOLECULAR & CELLULAR PROTEOMICS (2011)
The Selective Mu-Opioid Receptor Antagonist ADL5510 Reduces Levodopa-Induced Dyskinesia Without Affecting Antiparkinsonian Action in MPTP-Lesioned Macaque Model of Parkinson's Disease
James B. Koprich et al.
MOVEMENT DISORDERS (2011)
Effect of non-dopaminergic drug treatment on Levodopa induced dyskinesias in MPTP monkeys: Common implication of striatal neuropeptides
Mohamed Khalil Tamim et al.
NEUROPHARMACOLOGY (2010)
Locomotor response to L-DOPA in reserpine-treated rats following central inhibition of aromatic L-amino acid decarboxylase: Further evidence for non-dopaminergic actions of L-DOPA and its metabolites
Amal Alachkar et al.
NEUROSCIENCE RESEARCH (2010)
Distinct Changes in cAMP and Extracellular Signal-Regulated Protein Kinase Signalling in L-DOPA-Induced Dyskinesia
Emanuela Santini et al.
PLOS ONE (2010)
Dopamine Transporter Binding Is Unaffected by L-DOPA Administration in Normal and MPTP-Treated Monkeys
Pierre-Olivier Fernagut et al.
PLOS ONE (2010)
Striatal Alterations of Secretogranin-1, Somatostatin, Prodynorphin, and Cholecystokinin Peptides in an Experimental Mouse Model of Parkinson Disease
Anna Nilsson et al.
MOLECULAR & CELLULAR PROTEOMICS (2009)
30 years of dynorphins - New insights on their functions in neuropsychiatric diseases
Christoph Schwarzer
PHARMACOLOGY & THERAPEUTICS (2009)
Enhanced preproenkephalin-B-derived opioid transmission in striatum and subthalamic nucleus converges upon globus pallidus internalis in L-3,4-dihydroxyphenylalanine-induced dyskinesia
Incarnation Aubert et al.
BIOLOGICAL PSYCHIATRY (2007)
Phenotype of striatofugal medium spiny neurons in parkinsonian and dyskinetic nonhuman primates: A call for a reappraisal of the functional organization of the basal ganglia
Agnes Nadjar et al.
JOURNAL OF NEUROSCIENCE (2006)
Decreased striatal levels of PEP-19 following MPTP lesion in the mouse
K Sköld et al.
JOURNAL OF PROTEOME RESEARCH (2006)
Dynorphin A (2-13) improves mecamylamine-induced learning impairment accompanied by reversal of reductions in acetylcholine release in rats
M Hiramatsu et al.
NEUROPEPTIDES (2006)
Adaptive linear step-up procedures that control the false discovery rate
Yoav Benjamini et al.
BIOMETRIKA (2006)
The striatofugal fiber system in primates:: A reevaluation of its organization based on single-axon tracing studies
M Lévesque et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Increased striatal pre-proenkephalin B expression is associated with dyskinesia in Parkinson's disease
B Henry et al.
EXPERIMENTAL NEUROLOGY (2003)
Alterations in striatal neuropeptide mRNA produced by repeated administration of L-dopa, ropinirole or bromocriptine correlate with dyskinesia induction in MPTP-treated common marmosets
BC Tel et al.
NEUROSCIENCE (2002)
Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease
E Bezard et al.
JOURNAL OF NEUROSCIENCE (2001)
Des-tyrosine1 dynorphin A-(2-13) improves carbon monoxide-induced impairment of learning and memory in mice
M Hiramatsu et al.
BRAIN RESEARCH (2000)
分享论文
